Panbela Therapeutics FCF yield
Что обозначает FCF yield в Panbela Therapeutics?
FCF yield Panbela Therapeutics Inc. является -2,192.33%
Какое определение для FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield компаний в Health Care сектор на NASDAQ по сравнению с Panbela Therapeutics
Что делает Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Компании с fcf yield похож на Panbela Therapeutics
- Touchpoint имеет FCF yield из -2,790.72%
- Valeritas имеет FCF yield из -2,715.90%
- Rhino Resource Partners LP имеет FCF yield из -2,676.97%
- CARBO Ceramics имеет FCF yield из -2,674.78%
- Shiloh Industries имеет FCF yield из -2,671.82%
- Briggs & Stratton имеет FCF yield из -2,633.23%
- Panbela Therapeutics имеет FCF yield из -2,192.33%
- KKR & Co имеет FCF yield из -2,145.36%
- Endologix имеет FCF yield из -1,961.27%
- Basler Aktiengesellschaft имеет FCF yield из -1,839.17%
- Zovio Inc имеет FCF yield из -1,838.52%
- PhaseBio Pharmaceuticals имеет FCF yield из -1,833.88%
- Tailored Brands имеет FCF yield из -1,823.08%